New patent for Taiho Oncology drug LYTGOBI

Annual Drug Patent Expirations for LYTGOBI Lytgobi is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are two patents…

The post New patent for Taiho Oncology drug LYTGOBI appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog